Health Care [ 4/12 ] | Pharmaceuticals [ 14/72 ]
NASDAQ | Common Stock
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases.
Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease.
The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019.
The company was incorporated in 1998 and is based in Austin, Texas.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 10, 24 | 0.58 Increased by +200.00% | -0.46 Increased by +226.09% |
| Feb 28, 24 | -0.50 Decreased by -6.38% | -0.52 Increased by +3.85% |
| Nov 7, 23 | -0.61 Decreased by -19.61% | -0.77 Increased by +20.78% |
| Aug 3, 23 | -0.63 Decreased by -31.25% | -0.59 Decreased by -6.78% |
| May 1, 23 | -0.58 Decreased by -31.82% | -0.56 Decreased by -3.57% |
| Feb 28, 23 | -0.47 Decreased by -34.29% | -0.56 Increased by +16.07% |
| Nov 7, 22 | -0.51 Decreased by -112.50% | -0.48 Decreased by -6.25% |
| Aug 3, 22 | -0.48 Decreased by -269.23% | -0.43 Decreased by -11.63% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 0.00 Decreased by N/A% | -25.65 M Decreased by -33.82% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -26.38 M Decreased by -43.15% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -21.64 M Decreased by -25.57% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | -1.80 K Decreased by -800.00% | -17.33 M Decreased by -22.29% | Increased by +962.83 K% Decreased by -86.41% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -19.17 M Decreased by -100.47% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -18.43 M Decreased by -259.51% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -17.23 M Decreased by -388.74% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | -200.00 Decreased by N/A% | -14.17 M Decreased by -441.33% | Increased by +7.09 M% Decreased by N/A% |